Repligen
RGEN
#1835
Rank
โ‚ฌ10.19 B
Marketcap
159,49ย โ‚ฌ
Share price
3.04%
Change (1 day)
26.54%
Change (1 year)
Categories

Number of shares outstanding for Repligen (RGEN)

Number of shares outstanding as of November 2026 : 56,558,000

According to Repligen 's latest financial reports and stock price the company's current number of shares outstanding is 56,558,000. At the end of 2024 the company had 55,791,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Repligen from 1996 to 2024

Shares Outstanding at the end of each year

Year Shares Outstanding Change
202455.79 M-0.04%
202355.81 M0.49%
202255.54 M0.43%
202155.3 M4.07%
202053.14 M2.07%
201952.06 M18.65%
201843.88 M0.72%
201743.56 M28.77%
201633.83 M2.69%
201532.94 M0.61%
201432.74 M2.6%
201331.91 M2.52%
201231.13 M1.09%
201130.79 M0.03%
201030.78 M0.09%
200930.75 M-0.17%
200830.8 M-0.47%
200730.95 M1.9%
200630.37 M0.9%
200530.1 M0.13%
200430.06 M0.62%
200329.87 M9.38%
200227.31 M2.53%
200126.64 M0.25%
200026.57 M19.75%
199922.19 M47.96%
199815 M12.5%
199713.33 M-33.33%
199620 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
Pfizer
PFE
5,699,000,000 9,976.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
370,000,000 554.20%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
1,035,000,000 1,729.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2,043,000,000 3,512.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
389,616,000 588.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
164,574,000 190.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
101,000,000 78.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
156,090,000 175.98%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
193,423,000 241.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
48,021,000-15.09%๐Ÿ‡บ๐Ÿ‡ธ USA